The company
Onto Innovation Inc.
ONTO · NYSE
ONTO stood above a rising 150-day average in 48 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 20.7% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just dropped out
- Weeks in an uptrend
- out for 1
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $1.2M
- Officials’ trades on record
- 5
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 48 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
5 disclosed lines: House 5, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08 | sold | $1k–$15k | 12 May 2025filed 9 Jun 2025 |
| Robert P. Bresnahan, Jr. House: U.S. House ClerkPA08 | sold | $1k–$15k | 9 May 2025filed 9 Jun 2025 |
| Tom Malinowski House: U.S. House ClerkNJ07 | sold | $1k–$15k | 1 May 2020filed 5 Mar 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | sold | $1k–$15k | 30 Apr 2020filed 26 Aug 2021 |
| Tom Malinowski House: U.S. House ClerkNJ07 | sold | $1k–$15k | 21 Apr 2020filed 5 Mar 2021 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David Brian MillerDirector | sold | 2,000at $300.00 | 29 Sep 2026filed 1 Oct 2026 |
| Susan D. LynchDirector | sold | 1,000at $302.30 | 21 Aug 2026filed 25 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.